Smoore International's stock soared 5.17% during intraday trading on Wednesday, reflecting strong investor optimism toward the company's prospects.

The significant price movement is primarily driven by favorable regulatory news from the U.S. Food and Drug Administration (FDA) for the e-cigarette sector. The FDA recently granted PMTA approval for four Glas pod products featuring non-tobacco and non-menthol flavors, marking the first authorization of fruit-flavored e-cigarettes for market sale. Concurrently, the agency issued enforcement guidance stating that all unapproved ENDS and nicotine pouch products are illegal.

Analysts view Smoore International, a leading global atomization device supplier, as a key beneficiary of this regulatory shift. The company's underage-user identification technology is considered critical for FDA approval, positioning its clients and brands for faster regulatory clearance. This policy change is expected to allow compliant industry leaders to regain market share in flavored products while unapproved products face increased enforcement.